baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Halozyme Therapeutics/ US40637H1095 /

4/17/2025 9:59:57 PM	Chg. -0.02	Volume	Bid4/17/2025	Ask9:59:57 PM	High	Low
58.82USD	-0.03%	77,073 Turnover: 4.52 mill.	58.67Bid Size: 100	58.82Ask Size: 100	59.34	57.65

GlobeNewswire 3/18 Recursion Bolsters Board of Directors with Former FDA Principal Deputy Commissioner Dr. Namandjé Bum...

GlobeNewswire 2/12 Genmab Publishes 2024 Annual Report

GlobeNewswire 5/6/2024 The Benchmark Company Announces Upcoming Healthcare House Call VIRTUAL One-on-One Investor Conferenc...

GlobeNewswire 2/14/2024 Genmab Publishes 2023 Annual Report

GlobeNewswire 11/6/2023 Acumen Pharmaceuticals, Inc. and Halozyme Enter Global Collaboration and License Agreement to Develo...

GlobeNewswire 2/22/2022 Arcutis Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

GlobeNewswire 2/16/2022 Genmab Publishes 2021 Annual Report

GlobeNewswire 12/16/2021 Arcutis Appoints Mas Matsuda as General Counsel and Corporate Secretary

GlobeNewswire 12/15/2021 Surface Oncology Appoints Denice Torres as Chair of the Board of Directors

GlobeNewswire 9/2/2021 Crinetics Pharmaceuticals Expands Executive Team with Addition of Jeff Knight as Chief Operating Off...

GlobeNewswire 6/30/2021 TRACON Pharmaceuticals Announces Appointment of Ya Huang as Executive Director of Statistical Progra...

GlobeNewswire 5/26/2021 Novome Biotechnologies Appoints Dr. David N. Cook and Zachary Hornby to its Board of Directors

GlobeNewswire 5/12/2021 Medicenna Appoints Immuno-Oncology Expert Dr. Mann Muhsin as Chief Medical Officer

GlobeNewswire 3/15/2021 Iovance Biotherapeutics Appoints Igor Bilinsky as Chief Operating Officer

GlobeNewswire 3/1/2021 Cerecor Appoints Schond L. Greenway as Chief Financial Officer

GlobeNewswire 9/22/2020 Genmab Commences Binding Arbitration of Two Matters Under License Agreement with Janssen

GlobeNewswire 3/5/2020 Passage Bio Appoints Athena Countouriotis to Board of Directors

GlobeNewswire 11/12/2019 Bernadette Connaughton Appointed to Syneos Health Board of Directors

GlobeNewswire 7/2/2019 Madrigal Pharmaceuticals Announces Appointment of Jim Daly to Board of Directors

GlobeNewswire 6/11/2019 Iovance Biotherapeutics Appoints Athena Countouriotis, M.D., to Board of Directors

GlobeNewswire 2/28/2019 FDA approves Herceptin Hylecta for subcutaneous injection in certain HER2-positive breast cancers

GlobeNewswire 2/15/2019 Consolidated Research: 2019 Summary Expectations for Tenaris S.A, Rapid7, Halozyme Therapeutics, Car...

GlobeNewswire 2/4/2019 argenx and Halozyme enter global collaboration and license agreement for ENHANZE® technology

GlobeNewswire 12/27/2018 Factors of Influence in 2019, Key Indicators and Opportunity within Halozyme Therapeutics, Capricor ...

GlobeNewswire 12/11/2018 Biopharmaceutical Drug Delivery Device Technology - Global Markets to 2023: Trends & Developments

Halozyme Therapeutics/ US40637H1095 /

If you wish to receive reply to your feedback, please provide your email address.